The $110 figure is not an official published consensus. It is the arithmetic mean of 12 individually verified, split-adjusted price targets from sell-side firms. Because Amphenol executed a two-for-one stock split effective September 3, 2026, all figures below are post-split. The targets reviewed range from $90 at TD Cowen (Hold) to $122 at Goldman Sachs, a spread of roughly 35%.
Constructive views dominate. Barclays raised its target to $111, Truist to $112, Bank of America Securities to $110, J.P. Morgan and Citi to $115, UBS to $111, Evercore ISI to $100, Seaport Global to $115, and Bernstein to $99. Analysts broadly cite Amphenol's AI interconnect content, the CommScope Connectivity and Cable Solutions acquisition, and margin expansion. The more cautious end is led by TD Cowen's Hold and $90 target, while Rothschild & Co Redburn cut its target to $107 but continues to carry a sell recommendation. The overall rating tilt remains strongly bullish, with the overwhelming majority of tracked analysts at Buy or equivalent.
The stock last closed near $80 (about $79.95), so a move to $110 requires upside of approximately 38%. That is a very large move, not a modest re-rating. The company's fundamentals have been strong: fiscal Q3 2026 sales rose 65% year over year to a record $10.2 billion, adjusted EPS (earnings per share) climbed 74% to $0.80, and operating margin reached 29.7%. Orders hit a record $12.17 billion, up 99%, producing a book-to-bill ratio of 1.19, meaning Amphenol booked $1.19 in new orders for every $1.00 it shipped. For the shares to reach $110, investors would need to keep paying a growth multiple while AI-driven IT datacom demand continues to expand at the current pace.
The clearest engine is AI. IT Datacom made up roughly 48% of fiscal Q3 sales, and management has said AI accounts for about three-quarters of that segment. Record orders and a healthy book-to-bill ratio suggest demand momentum persists. Management also raised fourth-quarter guidance, lifted the quarterly dividend by 20% to $0.15 per share, and approved a new three-year, $4 billion buyback program. The CommScope acquisition broadens Amphenol's connectivity and cable-solutions footprint, and analysts have repeatedly cited improved content gains and margin execution as reasons for higher targets.
Concentration is the principal risk. With nearly half of sales tied to IT Datacom and AI spending, any slowdown in hyperscaler capital expenditure could quickly pressure both growth and the multiple. Amphenol's trailing P/E (price-to-earnings ratio) has hovered around 33 to 34 times, well above the S&P 500's low-20s multiple, leaving little room for disappointment. A smaller market, communications networks, has already weakened, with organic sales down 28% year over year. Sentiment has also turned cautious: the shares have pulled back amid post-election rotation away from AI-linked growth names, a roughly $66 million insider share sale, and technical selling below short-term moving averages.
The stock has slipped below its 20-day and 50-day moving averages (around $82 to $83) but remains above its 200-day moving average near $75.80, keeping the longer-term trend technically intact. That $75.80 area marks a key support level, while resistance sits near $78.70 and again around $82.55. A sustained move toward $110 would first require reclaiming those overhead levels and rebuilding momentum that has been missing since the late-October earnings report.
Analyst price targets generally reflect a roughly 12-month research horizon, though firms differ in methodology. The most important near-term catalyst is the next earnings report, expected in January 2027, where IT Datacom sales growth and order trends will be scrutinized. Investors should also watch hyperscaler AI capital-spending commentary, CommScope integration progress, any further analyst target revisions, and broader sector rotation. None of these items guarantees a move to $110.
Tickeron's AI Daily Buy/Sell Signals use artificial intelligence to continuously monitor thousands of stocks and ETFs, generating Buy, Sell, or Hold signals based on changing market conditions, technical behavior, and AI-driven analysis. The tool is designed to help traders identify opportunities, track positions, and spot shifting trends more efficiently than manual screening alone. For those following a fast-moving name like Amphenol, where sentiment and technicals can change quickly, such signals offer a useful complement to fundamental research and analyst views.
The $110 target, derived from the mean of 12 current analyst price targets, would require a roughly 38% advance from roughly $80, a very large move. Support rests on exceptional AI-driven demand, record orders, margin expansion, and shareholder-friendly capital returns. The obstacles are equally real: AI-spending concentration, a rich valuation, cautious outliers such as TD Cowen and Rothschild, and a technical backdrop that remains weak in the near term. Whether Amphenol reaches $110 depends on sustained AI demand and a willingness by the market to keep paying a premium multiple; neither is guaranteed, and investors should weigh the wide range of analyst views before drawing conclusions.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
A.I.dvisor indicates that over the last year, APH has been closely correlated with TEL. These tickers have moved in lockstep 66% of the time. This A.I.-generated data suggests there is a high statistical probability that if APH jumps, then TEL could also see price increases.
| Ticker / NAME | Correlation To APH | 1D Price Change % | ||
|---|---|---|---|---|
| APH | 100% | -1.75% | ||
| TEL - APH | 66% Closely correlated | -0.68% | ||
| BELFB - APH | 58% Loosely correlated | -3.43% | ||
| BELFA - APH | 58% Loosely correlated | -3.98% | ||
| BHE - APH | 58% Loosely correlated | -2.75% | ||
| CLS - APH | 56% Loosely correlated | -5.39% | ||
More | ||||